Menu

Agenda

Wednesday, March 20, 2019

12:00 pm Registration
12:00 pmExhibitor Set-Up
CORPORATE SPONSORED EDUCATIONAL SYMPOSIA
1:00 – 6:00 pmCorporate Sponsored Educational Symposia

Thursday, March 21, 2019

6:30 – 7:00 am Breakfast / Coffee
General Session
7:00 – 7:15 amWelcome Remarks & Sponsor Acknowledgements
  • Shalom Kalnicki, MD, President of the RSS Board of Directors
7:15 – 7:45 amKeynote Address: Value-Based Medicine in the Current Healthcare Economic Environment
  • TBD
Clinical Session
7:45 – 10:00 amSeesion I Clinical Abstract Presentations with Q&A
10:00 – 10:30 amCoffee Break / Visit with Exhibitors
10:30 am – 12:00 pmSession II Clinical Abstract Presentations with Q&A
12:00 – 1:30 pmLunch & Exhibit Hall Presentations
1:30 – 4:00 pmSession III Clinical Abstract Presentations with Q&A
4:00 – 4:30 pmAfternoon Break
PHYSICS Session
7:45 – 10:00 amSession I Physics Abstract Presentations with Q&A
10:00 – 10:30 amCoffee Break / Visit with Exhibitors
10:30 am – 12:00 pmSession II Physics Abstract Presentations with Q&A
12:00 – 1:30 pmLunch & Exhibit Hall Presentations/Visit with Exhibitors
1:30 – 2:45 pm

Artificial Intelligence and Quantitative Analysis Perspective on Radiation Oncology and SRS/SBRT Session

Moderators:

  • Stanley H. Benedict, PhD, FAAPM, University of California, Davis, Davis, CA
  • Timothy D. Solberg, PhD, FACR, FACMP, FAAPM, FASTRO, University of California, San Francisco, San Francisco, CA
  • Fang-Fang Yin, PhD, Duke University, Durham, NC

Current and future Artificial Intelligence in Radiation Oncology and SRS/SBRT
Jackie Wu, PhD, Duke University, NC

The Future of Quantitative Imaging in Radiation Oncology and SRS/SBRT
Olivier Morin, PhD, University of California, San Francisco, CA

2:45 – 4:00 pm

Quality Assurance as It Relates to Various Treatment Systems

Moderators:

  • Grace Kim, PhD, University of California, San Diego, San Diego, CA
  • Christoph Fürweger, PhD, European CyberKnife Center, Munich, Germany

Quality Assurance for MR-Guided Radiosurgery
James Balter, PhD, University of Michigan, Ann Arbor, MI

The Benefits of Monte Carlo-Based Secondary Dose Calculation in a Comprehensive QA Solution
Markus Alber, PhD, Heidelberg University, Heidelberg, Germany

IROC’s External Quality Assurance Audits for Radiosurgery
Stephen F. Kry, PhD, MD Anderson Cancer Center, Houston, TX

4:00 – 4:30 pmAfternoon Break/Visit with Exhibitors
General Session
4:30 – 5:45 pm
  • Tumor Control Probability Guidelines for SRS/SBRT

    As an evolving treatment modality in both the primary and recurrent setting, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is increasingly being used worldwide. It is well-recognized that the radiobiology of radiosurgery and its associated outcomes for a variety of tumor types remains a “works-in-progress.” In the Tumor Control Probability Guidelines” session, we will present the “state of the science” by recognized experts in the field of lung, head & neck and spine.

Moderator:

  • Dwight E. Heron, MD, MBA, FACRO, FACR, UPMC Hillman Cancer Center, Pittsburgh, PA

Overview
Jimm Grimm, PhD, Johns Hopkins Medical Center, Baltimore MD

Lung Guidelines
Percy P. Lee, MD, David Geffen School of Medicine, UCLA; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA

Spine Guidelines
Scott Soltys, MD, Stanford University Medical Center, Stanford, CA

Head & Neck Guidelines
Andy Clump, MD, PhD, UPMC Hillman Cancer Center, Pittsburgh, PA

5:45 – 6:00 pm“Best of” Clinical & Physics Abstract Awards
MARCH MADNESS MIX & MINGLE EVENT
6:00 – 8:00 pm

“March Madness” Reception

  • Mix and Mingle Evening Event
  • Poster Presentations
  • Walk With A Professor Poster Walk
  • Award Presentations

Friday, March 22, 2019

7:00 – 7:30 amLight Breakfast / Coffee
General Session
7:00 – 9:00 am

Current and Future Approaches to Combining Immunotherapy & Radiosurgery

A joint session hosted by the Radiosurgery Society (the RSS) in collaboration with the Society for Immunotherapy of Cancer (SITC).

Session Chairs:

  • Mansoor M. Ahmed, PhD, National Cancer Institute/National Institutes of Health, Rockville, MD
  • Marka Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

Opening Remarks
Mansoor M. Ahmed, PhD, National Cancer Institute/National Institute of Health, Rockville, MD

Cancer Immunology / Immunotherapy: A Primer for Radiation Oncologists & Medical Physicists
Alice O. Kamphorst, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Opportunities and Challenges of Combining SBRT and Immunotherapy
Stephen L. Shiao, MD, PhD, Cedars-Sinai Medical Center and University of California, Los Angeles, Los Angeles, CA

Combining Interleukin-2 and SBRT for Melanoma
Marka R. Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

FLT3 Ligand and SBRT for Lung Cancer
Chandan Guha, MBBS, PhD, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Combination Immunotherapy and SBRT for Head & Neck Cancer
Nadeem Riaz, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Closing Remarks
Marka R. Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

9:00 – 10:00 am
  • Recent Developments in SRS for Functional Diseases

    Brain science continues to evolve and along with it so must diagnoses and treatment options. Optimizing patient care by combining clinical and technological breakthroughs; incorporating artificial intelligence and brain-fusion techniques; and collaboration with innovation are critical to advancing functional neurological treatment breakthroughs. This session will highlight the advancements in the treatment of Parkinson’s Disease, Epilepsy, Trigeminal Neuralgia, Obsessive Compulsive Disorders and Essential Tremors using Stereotactic Radiosurgery from a few of the world’s leading neurosurgeons.

Moderator:

  • Michael Schulder, MD, FAANS, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

SRS for Obsessive Compulsive Disorder and Essential Tremor
TBA

SRS for Parkinson’s and Epilepsy
Sameer Seth, MD, PhD, Baylor College of Medicine, TX

SRS for Trigeminal Neuralgia
Konstantin V. Slavin, MD, University of Illinois at Chicago, Chicago, IL

SRS vs Focused Ultrasound
Casey Halpern, MD, Stanford University Medical Center, Stanford, CA

10:00 – 10:30 amCoffee Break/Visit with Exhibitors
10:30 – 12:00 pm

Building Collaborative Teams around SRS/SBRT: Exchanging Experiences and Addressing Challenges

Moderators:

  • Susan Pannullo, MD, FAANS, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • Michael Schulder, MD, FAANS, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

Program details to come…

12:00 – 1:30 pmLunch & Presentations in Exhibit Hall
MARCH MADNESS SHOWDOWN DEBATES
1:30 – 1:45 pmShowdown Debate Opening Remarks
1:45 – 3:00 pm

Debate I: SRS vs Whole Brain Radiation Therapy for Brain Metastases - Is SRS a Slam Dunk for Brain Metastases?

Presented by:

  • Hany Soliman, MD, FRCPC, Assistant Professor, University of Toronto, Toronto, Canada
  • Mark V. Mishra, MD, University of Maryland Medical System, Baltimore, MD
3:00 – 4:15 pm

Debate II: SBRT vs Focal Ablation Therapy for Primary Renal Cell Carcinoma – Let the Madness Begin

Presented by:

  • Lee Ponsky, MD, FACS, University Hospitals Cleveland Medical Center, Cleveland, OH
  • Shankar Siva, PhD, MBBS, FRANZCR, Sir Peter MacCullum Cancer Center, Melbourne, Australia
4:15 – 4:45 pmCoffee Break/Visit with Exhibitors
AFTERNOON BREAKOUT SESSIONS
4:45 – 6:00 pm

Concurrent Sessions:

  • RSSearch® Patient Registry Breakout
  • Residents’ Breakout
EVENING ON OWN

Saturday, March 23, 2019

7:30 – 8:30 amBreakfast
General Session
8:00 – 10:00 am

Performance & Quality Improvement Session with Case-Based Discussions

Individual case presentations based on submissions.

Moderators:

  • Richard D. Bucholz, MD, FACS, St. Louis University Hospital Medical Center, St. Louis, MO
  • John J. Kresl, MD, PhD, DABR, FACR, FACRO, Phoenix CyberKnife & Radiation Oncology Center, Phoenix, AZ

This session is restricted – no guest, commercial vendors, exhibitor or staff will be allowed into the room.

10:00 – 10:30 amCoffee Break/Visit with Exhibitors
10:30 am – Noon

Dosimetry Plan Study – SBRT for Pancreatic Cancer

Announcement and presentations of top performing submitted cases.

A joint session hosted by the Radiosurgery Society (the RSS) in collaboration with the American Association of Medical Dosimetrists

Session Chair:

  • Anand Mahadevan, MD, Geisinger Medical Center, Danville, PA

Expert Panelists:

  • Steve Burton, MD, UPMC Hillman Cancer Center, Pittsburg, PA
  • Daniel Chang, MD, Stanford University Medical Center, Stanford, CA
  • Amol Narang, MD, Johns Hopkins Medicine, Baltimore, MD
  • Brian Wang, PhD, University of Louisville, Louisville, KY
  • Grace Kim, PhD, University of San Diego, San Diego, CA

Individual Case Presentations based on Submissions

Noon – 1:00 pmLunch/Visit with Exhibitors/RSS Annual Meeting
1:00 – 2:30 pm

Didactic Session (no charge to attend)

  • Lung SABR/SBRT: Current Challenges and Future Directions Workshop

    The RSS will be holding a special lecture series and hands-on workshop focused on the current challenges of lung stereotactic body radiotherapy (SBRT) treatment planning and delivery, the conundrum of post SBRT follow up imaging and recommended practices and updates from the clinical trials on SBRT for early-stage operable lung cancer. The session will also explore single fraction radiosurgery for thoracic tumors and future indications for lung SBRT. The lecture series will be open to all registered 2019 RSS Scientific Meeting attendees. The Hands-On Workshop will be held immediately after the lecture series and will focus on clinical case discussions, contouring, treatment planning tips and tricks by the expert panel and demonstrations by various Corporate Vendors. There is an additional registration fee for the Hands-On Workshop and limited attendance.

Session Chairs:

  • Drew Moghanaki, MD, VCU Massey Cancer Center, Richmond, VA
  • Ben J. Slotman, MD, PhD, FACR, VU University Medical Center, Amsterdam, Netherlands

SABR for Operable Stage I NSCLC: Lessons Learned from the VALOR Trial
Drew Moghanaki, MD, VCU Massey Cancer Center, Richmond, VA

Evolving Paradigms for Lung SBRT
Pam Samson, MD, Washington University, St. Louis, MO

The Conundrum of Post-SBRT Thoracic Imaging
Ben J. Slotman, MD, PhD, FACR, VU University Medical Center, Amsterdam, Netherlands

SBRT for Metastatic Lung Cancer
Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia

2:30 – 4:30 pm

Lung SBRT Hands-On Workshop*

Moderator:

  • Brian Wang, PhD, University of Louisville, Louisville, KY

Common Mistakes with Lung SBRT: Lessons from LUSTRE
Anand Swaminath, MD, MacMaster University, Hamilton, Canada

Vendor Station Rotations and Presentations:
Clinical cases, treatment planning tips and tricks, and pearls and pitfalls. Attendees will have 20-minute rotations to learn and interact with Corporate Vendors and Expert Panelists.

Panelists:

  • Pam Samson, MD, Washington University, St. Louis, MO
  • Anand Swaminath, MD, McMaster University, Hamilton, Canada
  • Drew Moghanaki, MD, VCU Massey Cancer Center, Richmond, VA
  • Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia

* Limited attendance, additional registration fee to attend.

RSS Members: $55.00
Non-RSS Members: $85.00

4:30 pmMeeting Adjourns

Session Descriptions

Tumor Control Probability Guidelines for SRS/SBRT
As an evolving treatment modality in both the primary and recurrent setting, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is increasingly being used worldwide. It is well-recognized that the radiobiology of radiosurgery and its associated outcomes for a variety of tumor types remains a “works-in-progress.” In the Tumor Control Probability Guidelines” session, we will present the “state of the science” by recognized experts in the field of lung, head & neck and spine.

Recent Developments in SRS for Functional Diseases
Brain science continues to evolve and along with it so must diagnoses and treatment options. Optimizing patient care by combining clinical and technological breakthroughs; incorporating artificial intelligence and brain-fusion techniques; and collaboration with innovation are critical to advancing functional neurological treatment breakthroughs. This session will highlight the advancements in the treatment of Parkinson’s Disease, Epilepsy, Trigeminal Neuralgia, Obsessive Compulsive Disorders and Essential Tremors using Stereotactic Radiosurgery from a few of the world’s leading neurosurgeons.

Lung SABR/SBRT: Current Challenges and Future Directions Workshop
The RSS will be holding a special lecture series and hands-on workshop focused on the current challenges of lung stereotactic body radiotherapy (SBRT) treatment planning and delivery, the conundrum of post SBRT follow up imaging and recommended practices and updates from the clinical trials on SBRT for early-stage operable lung cancer. The session will also explore single fraction radiosurgery for thoracic tumors and future indications for lung SBRT. The lecture series will be open to all registered 2019 RSS Scientific Meeting attendees. The Hands-On Workshop will be held immediately after the lecture series and will focus on clinical case discussions, contouring, treatment planning tips and tricks by the expert panel and demonstrations by various Corporate Vendors. There is an additional registration fee for the Hands-On Workshop and limited attendance.

For event questions, email rssevents@therss.org